2022-Dec-22

Investor Relations News QIV 2022

more...

2022-Oct-12

Investor Relations News QIII 2022

MetrioPharm at BioPharm America in Boston, USA, Company Calendar in QIV 2022, MetrioPharm blog, MetrioPharm at Linkedin

more...

2022-Jun-30

Investor Relations News QII 2022

16th Annual General Meeting of MetrioPharm AG, Bio-Europe Spring in Basel, BIO International Convention in San Diego, Company Calendar, London-Paris in 24 hours, MetrioPharm AG informs

more...

2022-Mar-31

Investor Relations News QI 2022

Outlook by the Chairman of the Board Rudolf Stäger

more...

2021-Dec-21

Investor Relations News QIV 2021

Greetings from CEO Thomas Christély

more...

2021-Oct-01

Investor Relations News QIII 2021

Topics: Greetings from CEO Thomas Christély, MetrioPharm in the Media

more...

2021-Jun-30

Investor Relations News QII 2021

Topics: 15th Annual General Meeting of MetrioPharm AG, MetrioPharm in the Media

more...

2021-Mar-31

Investor Relations News QI 2021

Holiday Greetings from CEO Dr. Wolfgang Brysch 

more...

2021-Feb-27

Investor Relations News Update

MetrioPharm in the media (ARD, RBB): "The necessity of therapeutics in the fight against the corona pandemic", "Possible use of MP1032 in acute illness of patients with Covid-19"

more...

2020-Dec-21

MetrioPharm Investor Relations News QIV 2020

Greetings by CEO Dr. Wolfgang Brysch: "Our lead compound MP1032 is a highly promising candidate for the treatment of Covid-19.", MetrioPharm in the Media

more...